Skip to content
NxGEN Vector Solutions, LLC
  • About us
  • Our Technology
  • The Science
  • Cardiac Gene Therapy
  • Newsroom
  • Contact Us

September 8th, 2020 - September 8, 2020 – Partner with NxGEN Vector Solutions to apply NxGEN Technology to your AAV vectors and eliminate the immune response that limits transgene durability. Learn more in the May issue of Genetic Engineering & Biotechnology News (GEN Magazine) on pages 10-11.

Click here to view GEN Magazine, Cell and Gene Therapy Supplement

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook

Related

Post navigation

June 1, 2020 – NxGEN Vector Solutions presented the abstract entitled, ‘CpG-Motifs within AAV Vectors Trigger Immune Activation upon Hepatic Gene Transfer’ at the 23rd Annual Meeting of American Society of Gene and Cellular Therapy, Boston, Massachusetts, on May 13, 2020.
October 6, 2020 — NxGEN Vector Solutions received trademark protection for the NxGEN logo.

NxGEN Vector Solutions, LLC
455 Massachusetts Ave., N.W., Suite 369
Washington, D.C. 20001
p: 202.765.7475
www.nxgenvectorsolutions.com

About Us
• Our Founder and Members
Our Technology
• The Science
• The Technical Details
Newsroom
Construct Design & Consulting
Contact Us
• Privacy
  Facebook
  Twitter

copyright © 2018 NxGEN Vector Solutions, LLC